Edge AI Is Reshaping How Clinical Trials Run

By John Oncea, Editor

My predecessor, Dan Schell, attended the recent SCOPE Summit in Orlando, where he and Joe Dustin, currently self-employed as a consultant for Dauntless Clinical Strategies, discussed why sites are increasingly digitizing their operations.

Dustin acknowledges that sponsor requirements play a role in this evolution, but feels sites – driven by private equity investment, consolidation, and the need to reduce administrative overload – would be doing so even without sponsor prompting.

Regardless of why it’s happening, Dustin says, as a result, sites are seeing a corresponding increase in the size and complexity of their eClinical stacks, covering everything from trial management to eConsent and recruitment.

Schell writes that, “Despite the promise of digitization, the burden of technology remains one of the most persistent frustrations for sites.” Sponsors routinely deploy 15 to 20 systems per study, forcing coordinators into repetitive manual data entry across multiple platforms, a problem rooted in workflow habits that never evolved when EDC systems were first introduced.

One proposed solution, according to Dustin, is a bring your own technology (BYOT) model, allowing sites to use their preferred systems while securely transmitting data to sponsors via standardized integration,  eliminating duplication and reducing startup timelines. “If the site says, ‘I’d rather use my tech than yours and connect it so I don’t have to learn a new system,’ you get data much faster and eliminate manual work,” explains Dustin.

Dustin adds that AI is beginning to play a bigger role as well by helping automate repetitive work and streamlining processes that have historically required manual duplication. Which brings us close to the edge.

Edge Computing Explained

In a previous life, I wrote about edge computing, noting that, unlike traditional computing models that send data to a centralized cloud server for processing, it brings processing and data storage closer to the source of data generation. In other words, edge computing performs data processing and analysis right at the “edge” of the network, resulting in reduced latency, bandwidth efficiency, improved privacy and security, offline capability, scalability, real time insights, and cost efficiency.

Consider a self-driving car navigating a busy intersection. Every millisecond, its cameras, LiDAR, and sensors are generating enormous volumes of data: reading lane markings, tracking pedestrians, and monitoring vehicle speed.

Sending all of that raw data to a remote server for analysis and waiting for instructions back simply isn’t an option when a child steps off the curb. The vehicle’s onboard edge computing system processes everything locally, making real-time decisions in fractions of a second. No lag. No dependency on a strong network connection. No life-or-death outcome hinging on cloud availability.

That same principle scales across industries and the benefits compound. Processes are faster and more automated, bandwidth demands drop, and the collective processing power of distributed devices can be leveraged, all without depending on a central server or a persistent cloud connection.

Bringing Edge To Clinical Trials

That same principle is now reshaping one of the most data-intensive fields in medicine: clinical research.

Consider a wearable heart monitor worn by a patient enrolled in a clinical trial. Rather than continuously transmitting raw cardiac data to a remote server for analysis, an edge-enabled device processes that data locally, detecting irregularities in real time, alerting the patient or care team instantly, and only sending relevant findings upstream. No lag. No dependency on a strong internet connection. No sensitive health data unnecessarily traveling across networks.

This is edge computing applied to clinical trials, and it is only the beginning.

Real-Time Patient Monitoring: Edge-AI frameworks combining federated learning, blockchain, and encryption are being deployed to enable secure, real-time anomaly detection in patient monitoring, processing vital signals like heart rate, temperature, and oxygen saturation directly on edge devices with over 91% accuracy, according to Scientific Reports. These systems also reduce server workload by processing data locally before transmission, achieving up to an 83% reduction in data uploads, meaningfully improving stability and sustainability for real-time clinical applications.

Decentralized & Remote Trials: The reach of clinical trials has historically been constrained by geography. Edge computing is changing that. MIT collaborated with a medical company to deploy edge computing devices on ambulances, monitoring patients’ vital signs in real time through onboard sensors. Separately, according to ACM conference proceedings, a German company developed portable ultrasound diagnostic equipment with embedded edge AI algorithms capable of analyzing data on-site and generating reports immediately with no connectivity required. Together, these innovations are enabling trials to reach patients in remote or resource-constrained environments that were previously inaccessible.

Wearables & Continuous Data Collection:

According to JMIR mHealth and uHealth, wearable ECG monitors with on-device arrhythmia detection represent a fast-growing segment of the cardiac monitoring market, reflecting how decisively edge computing has extended clinical care beyond traditional settings. For trials requiring long-term, real-world patient data, the ability to continuously monitor without burdening central infrastructure is a significant operational advantage.

AI-Driven Trial Efficiency: The efficiency gains extend well beyond monitoring, according to Science Direct. Across the trial life cycle, AI integration has delivered measurable results: patient recruitment tools have improved enrollment rates by 65%, predictive analytics models have achieved 85% accuracy in forecasting trial outcomes, and AI-assisted workflows have accelerated trial timelines by 30–50% while reducing costs by up to 40%.

Privacy-Preserving Federated Learning: One of the most consequential advantages of edge AI in clinical research is what it does with sensitive data, which is to say, as little as possible, according to npj Digital Medicine. Because processing happens locally on edge devices, patient data doesn’t need to leave the device at all. This enables real-time, energy-efficient, privacy-preserving machine learning across applications ranging from intelligent wearable sensors and implantable medical devices to clinical decision support systems.

What’s Next

Looking further ahead, clinical trial design is expected to be reshaped by AI-powered simulation and richer real-world data integration. Agentic AI – systems capable of autonomously taking action, not just generating insights – is emerging as the dominant theme for the industry, according to Nature Biotechnology.

Taken together, edge AI is driving a fundamental shift in how clinical trials are designed and executed — away from centralized, clinic-bound models and toward distributed, real-time, privacy-conscious research that is faster, less costly, and far more inclusive.